{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:10:53Z","timestamp":1779927053061,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neurobiolaging.2018.09.030","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:45:16Z","timestamp":1538070316000},"page":"171-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Comparison of longitudinal A\u03b2 in nondemented elderly and Down syndrome"],"prefix":"10.1016","volume":"73","author":[{"given":"Dana L.","family":"Tudorascu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davneet S.","family":"Minhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Comer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2243-3547","authenticated-orcid":false,"given":"Patrick","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigan","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Laymon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Snitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Lopresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-545X","authenticated-orcid":false,"given":"Sterling","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Aizenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-0251","authenticated-orcid":false,"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Handen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Amyloid deposition is frequent and often is not associated with significant cognitive impairment in the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005072-199005000-00003","article-title":"Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes","volume":"49","author":"Braak","year":"1990","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuroimage.2014.11.055","article-title":"Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction","volume":"108","author":"Brendel","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2967\/jnumed.114.149732","article-title":"Improved power for characterizing longitudinal amyloid-beta PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region","volume":"56","author":"Chen","year":"2015","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib32","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal Cerebral Metabolism May Modulate the Cognitive Effects of A\u03b2 in Mild Cognitive Impairment: An Example of Brain Reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","article-title":"Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition","volume":"14","author":"Cohen","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib6","first-page":"153","article-title":"Histopathological studies on senile plaques in brains of patients with Down's syndrome","volume":"36","author":"Fukuoka","year":"1990","journal-title":"Kobe J. Med. Sci."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib7","series-title":"Dementia Scale for Down Syndrome","author":"Gedye","year":"1995"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","article-title":"Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B","volume":"8","author":"Handen","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib9","doi-asserted-by":"crossref","first-page":"P20","DOI":"10.1016\/j.jalz.2016.06.023","article-title":"Pet staging of amyloidosis: evidence that amyloid occurs first in neocortex and later in striatum","volume":"12","author":"Hanseeuw","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205012666151020114607","article-title":"Aging in Down syndrome and the development of Alzheimer's disease neuropathology","volume":"13","author":"Head","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2307\/2533558","article-title":"Small sample inference for fixed effects from restricted maximum likelihood","volume":"53","author":"Kenward","year":"1997","journal-title":"Biometrics"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(95)11678-P","article-title":"Early amyloid-beta deposits show different immunoreactivity to the amino- and carboxy-terminal regions of beta-peptide in Alzheimer's disease and Down's syndrome brain","volume":"193","author":"Kida","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib15","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jalz.2015.05.013","article-title":"The effects of normal aging on amyloid-beta deposition in nondemented adults with down syndrome as imaged by carbon 11-labeled Pittsburgh compound B","volume":"12","author":"Lao","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2017.05.001","article-title":"Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented down syndrome population","volume":"9","author":"Lao","year":"2017","journal-title":"Alzheimers Dement. (Amst)."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid \u00ce2-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.55.12.1854","article-title":"Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades","volume":"55","author":"Lopez","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/neur.1996.0017","article-title":"Diffuse plaques in the cerebellum and corpus striatum in Down's syndrome contain amyloid beta protein (A beta) only in the form of A beta 42(43)","volume":"5","author":"Mann","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib21","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/WNL.0000000000000721","article-title":"Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease","volume":"83","author":"McDade","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib23","first-page":"748","article-title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","volume":"140","author":"Pontecorvo","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib24","doi-asserted-by":"crossref","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","article-title":"Increased in\u00a0vivo amyloid-beta 42 production, exchange, and loss in presenilin mutation carriers","volume":"5","author":"Potter","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev.neuro.21.1.479","article-title":"Mutant genes in familial Alzheimer's disease and transgenic models","volume":"21","author":"Price","year":"1998","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib33","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neuroimage.2010.12.070","article-title":"Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET","volume":"55","author":"Rosario","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in\u00a0vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroimage.2016.08.056","article-title":"Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE","volume":"144","author":"Schwarz","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/awu046","article-title":"Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease","volume":"137","author":"Shinohara","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.09.030_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00259-012-2088-x","article-title":"Comparison of 11C-PiB and 18F-florbetaben for Abeta imaging in ageing and Alzheimer's disease","volume":"39","author":"Villemagne","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T06:21:43Z","timestamp":1605075703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018303555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"alternative-id":["S0197458018303555"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.030","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of longitudinal A\u03b2 in nondemented elderly and Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}